Table 5.
The joint action of silver nanoparticles with pomegranate and watermelon peels extracts. (mean ± SD).
| Treatments | Combined concentration (µg/ml) | Observed mortality (%) | Expected mortality (%) | co-toxicity factor | Interaction |
|---|---|---|---|---|---|
| PPAgNPs + PPWE | 8.5 + 1000 | 20.00e | 10.00e | + 100.00 ± 0.0a | synergism |
| 17 + 2000 | 56.67c | 52.00b | + 8.98 ± 0.1d | additive | |
| 34 + 4000 | 90.00a | 78.33a | + 15.38 ± 0.3c | additive | |
| WPAgNP + WPWE | 8.5 + 1000 | 18.00e | 12.00e | + 50.86 ± 0.9b | synergism |
| 17 + 2000 | 33.33d | 22.66d | + 47.06 ± 0.8b | synergism | |
| 34 + 4000 | 62.00b | 45.55c | + 12.52 ± 0.4c | additive |
Pomegrante peels water extrat (PPWE); watermelon peels water extrat (WPWE); silver nanoparticles fabricated by pomegrnate peels extract (PPAgNPs); silver nanoparticles fabricated by watermelon peels extract (WPAgNPs).Data are preseted means ± SD. Means with different lowercases at the same column indicate significant differences